[1]
C. Sankey, MD, CCFP (EM), B. Setnik, PhD, Z. Harsanyi, BSc (Hon), MLS, MBA, PStat. (SSC), PSTAT® (ASA), K. Michalko, PharmD, MBA, Z. Yang, PhD, and P. Geoffroy, MDCM, MSc, FCFP, DABAM, “Opioid use following the introduction of an extended-release oxycodone formulation with tamper-resistant properties: Prospective historical chart review in methadone-maintained patients”, J of Opioid Management, vol. 12, no. 2, pp. 149–159, Mar. 2016.